NCT00488202

Completed

Advanced Ovarian Cancer and Sexuality Phase 1

University of British Columbia Source

Compare

Other study identifiers

Sponsor study identifier

H06-03235

Study Type

observational

Actual enrollment (reported)

26

Locations

1 country

Sites

2

Timeline

Study Start

May 2007

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

August 2011

Actual (reported)

Study Completion

August 2011

Actual (reported)

Brief Summary

Women with Advanced Ovarian Cancer (AOC) suffer from severe sexual side effects from treatment. The prevalence of the sexual issues is not known. The degree to which these sexual side effects is affected by treatment is also not known, as the literature in this area focuses on post-treatment analysis. Specific Aim #1 (Quantitative Phase): To determine the prevalence and types of sexual difficulties using self-report questionnaires in women about to receive treatment for Stage III or IV Ovarian Cancer at the BCCA and over time, and to correlate these symptoms with degree of cancer symptoms, well-being, depressive symptoms, and relationship satisfaction

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 26 participants
Study completion date: August 2011
Actual (reported)
Listed locations: 1 countries · 2 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
May 2007
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
June 18, 2007
Actual (reported)
First Posted
June 20, 2007
Actual (reported)
Primary Completion
August 2011
Actual (reported)
Study Completion
August 2011
Actual (reported)

Last Updated: June 1, 2017
Status Verified: May 2017
Last Update Submitted: May 30, 2017

Conditions

Ovarian Cancer Sexual Function

Keywords

Advanced Ovarian CancerSexual Function

Eligibility Criteria

Age19 Years - 65 Years

Sexfemale

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

women diagnosed with advanced ovarian cancer

You may qualify if:

Women with Advanced Ovarian Cancer (AOC) who have not received treatment yet, but who are seeking treatment at the BC Cancer Agency.
Women must be able to understand English enough to fill out the questionnaire packages.
Mastery of written English is required. No translation services will be available for this study.

You may not qualify if:

Anyone without an AOC diagnosis, who are not seeking treatment at BCCA, or who cannot understand enough English to complete the questionnaires will be excluded.

Sponsors & Collaborators

University of British Columbia
Otherlead

Study Sites (2)

UBC Sexual Health Lab, Vancouver Hospital

Vancouver, British Columbia, V5M 1M9, Canada

UBC Sexual Health Lab

Vancouver, British Columbia, V5Z 1M9, Canada

MeSH Terms

Conditions

Ovarian Neoplasms

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Neoplasms, FemaleUrogenital NeoplasmsGenital DiseasesEndocrine System DiseasesGonadal Disorders

Study Officials

Lori A Brotto, PhD
UBC
PRINCIPAL INVESTIGATOR

Enrollment

26 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: RETROSPECTIVE
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Principal Investigator

Study Record Dates

First Submitted

June 18, 2007

First Posted

June 20, 2007

Study Start

May 2007

Date type not reported

This date has not been verified as actual or estimated.

NCT00463996

MRI in Staging Ovarian Cancer Using MRI Contrast Agent

Unknown

NCT00617188

Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer

Phase 2Completed

NCT00757952

Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction

Completed

NCT00486707

Ovarian Cancer Patient Questionnaire on Genetic Testing

Completed

NCT00804258

Palliative Care During Intraperitoneal Chemotherapy in Patients With Ovarian Cancer

Completed

NCT00426257

Secondary Debulking Surgery +/- Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer

Phase 3Completed

Those who do not have a mastery of written English are excluded.

Contact the study team to confirm eligibility.

Primary Completion

August 2011

Actual (reported)

Study Completion

August 2011

Actual (reported)

Last Updated

June 1, 2017

Record last verified: 2017-05

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00488202
Data provider: ClinicalTrials.gov
Source updated: 2017-06-01
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:20:11 UTC

Locations

CA(2)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (2)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations